Alprostadil 500 mcg/mL Injectable — Class II drug recall D-0089-2019
Terminated recall by Westlab Pharmacy, Inc. dba Westlab Pharmacy, reported 2018-10-31, distributed nationwide. Incorrect Product Formulation
| Recall number | D-0089-2019 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Westlab Pharmacy, Inc. dba Westlab Pharmacy, Gainesville, FL, United States |
| Recall initiated | 2018-08-10 |
| Classified | 2018-10-24 |
| Reported by FDA | 2018-10-31 |
| Terminated | 2020-05-07 |
| Distributed | Nationwide (US) |
| Quantity | 80 syringes |
| NDC | 10002-7335-00 |
Product
Alprostadil 500 mcg/mL Injectable, Vials, Westlab Pharmacy, Inc., Gainesville, FL 32607 NDC 10002-7335-00
Reason for recall
Incorrect Product Formulation
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0089-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.